1 / 8

Rocuronium

Rocuronium. New drug authorized to administer by DHS. BUT is limited to use in a successfully intubated patient. Rocuronium. Description: Neuromuscular blocking (paralyzing) agent Mechanism of action:

candace-boyer
Download Presentation

Rocuronium

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rocuronium New drug authorized to administer by DHS. BUT is limited to use in a successfully intubated patient.

  2. Rocuronium Description: Neuromuscular blocking (paralyzing) agent Mechanism of action: Produces neuromuscular blockade by competing with acetylcholine for cholinergic receptors at the motor end plate. Half-life: Rocuronium has a biphasic distribution. The rapid distribution half-life is 1 to 2 minutes, and the slower distribution half-life is 14 to 18 minutes. Rocuronium has no effect on consciousness or pain threshold. Therefore, when rocuronium is used, adequate analgesia and sedation should be administered.

  3. Rocuronium Description: Neuromuscular blocking (paralyzing) agent Mechanism of action: Produces neuromuscular blockade by competing with acetylcholine for cholinergic receptors at the motor end plate. Half-life: Rocuronium has a biphasic distribution. The rapid distribution half-life is 1 to 2 minutes, and the slower distribution half-life is 14 to 18 minutes. Rocuronium has no effect on consciousness or pain threshold. Therefore, when rocuronium is used, adequate analgesia and sedation should be administered.

  4. Rocuronium • No effects on HR or BP • Reliable and controllable duration of action • Fast onset • Stable hemodynamics/no histamine release • Supplied: Solution as 10mg/cc vials of 50mg. Stable for 60 days at room temperature.

  5. Reversal Agent • It’s effects may be reversed by administering an anticholinesterase such as Prostigimine. Which increases the amount of acetylcholine at the receptors to compete with rocuronium. • But not in EMS scope of practice in AZ • Reversal of blockade virtually is never indicated following emergency airway management. • Atropine 0.01mg per kg IV is given to block excessive muscarinic stimulation (SLUDGE syndrome) • .

  6. Maintenance/Pain Management • Midalzolam 5mg/PRN • Morphine Same MS protocol for pain 2 mg initial dose 2-6 mg subsequent doses max. 20mg Remember: None of the previously reviewed medications: Etomidate, Succinylcholine, Versed, and Rocuronium are analgesics. Treat your patients pain!

  7. Midazolam (Versed) • Short-acting sedative hypnotic • Benzodiazepine • Water-soluble • CNS depressant and causes significant amnesia following administration • Has some muscle relaxant thus serves to calm and sedate patients, relax skeletal muscles, and, in high doses, causes sleep. • Midazolam DOES NOT have analgesic properties.

  8. Questions?

More Related